4.28
Finanzdaten der Adicet Bio Inc-Aktie (ACET)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
3.39%
22.30
|
21.57 | 31.89 | 27.95 | 32.39 |
| Interest Income/Expense |
4.35%
0.022
|
0.023 | 0.024 | 0.012 | - |
| Depreciation and Amortization |
10.58%
1.20
|
1.342 | 1.473 | 1.60 | 1.60 |
| Operating Income/Loss |
3.39%
-22.30
|
-21.57 | -31.89 | -27.95 | -32.39 |
| Income/Loss From Continuing Operations Before Tax |
4.80%
-21.21
|
-20.24 | -30.52 | -26.86 | -31.22 |
| Income Tax Expense/Benefit |
0.143
|
- | - | - | - |
|
|
5.50%
-21.36
|
-20.24 | -30.52 | -26.86 | -31.22 |
| Basic Average Shares |
0.01%
10.75
|
10.74 | - | 91.09 | 91.09 |
| Diluted Average Shares |
0.01%
10.75
|
10.74 | - | 91.09 | 91.09 |
| Basic Earnings Per Share |
5.85%
-1.99
|
-1.88 | - | -0.29 | -0.34 |
| Diluted Earnings Per Share |
5.85%
-1.99
|
-1.88 | - | -0.29 | -0.34 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):